Weng C Y, Li Z F, Hu S D, Luo Y S, Feng X T, Zhong Q, Zhang Q, Shen J
Department of Endocrinology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.
Zhonghua Nei Ke Za Zhi. 2019 Aug 1;58(8):577-583. doi: 10.3760/cma.j.issn.0578-1426.2019.08.006.
To evaluate life quality of Graves orbitopathy (GO) patients using Graves orbitopathy quality-of-life questionnaire (GO-QOL) and explore the influence factors of the quality of life of GO patients. This was a cross-sectional study conducted at The Third Affiliated Hospital of Southern Medical University including 145 newly diagnosed GO patients. All the patient answered the GO-QOL and underwent ophthalmic and endocrine assessments. The main outcome measures were the scores on GO-QOL 2 subscales: visual functioning and appearance. Based on the classification in the guideline of European Group on Graves Orbitopathy (EUGOGO), the patients were divided into two groups: mild and moderate to severe groups. Then the scales between these two groups were compared and influencing factors were analyzed. Finally, the floor and ceiling effects were assessed. The GO-QOL scores for the subscales of visual functioning and appearance were 70.91±27.83 and 61.29±26.37 respectively in 145 GO patients. Visual functioning and appearance were lower in moderate to severe group (62.71±28.77 and 57.52±26.49, respectively) than in mild group (85.58±18.77 and 68.02±24.99, respectively).The GO-QOL scores for the visual functioning subscale were significantly correlated with age (=0.002), clinical active score (=0.011) and the degree of diplopia (=0.00, (2)=0.373). The GO-QOL scores for the appearance were significantly correlated with sex (=0.05) and thyroid-stimulating hormone levels (=0.001, (2)=0.231). No significant ceiling or floor effects were observed for either subscale of the GO-QOL. With the aggravation of the disease, the quality of life of GO patients is getting worse and worse. The main influencing factors of the quality of life of GO patients include age, gender, diplopia, clinical active score and thyroid-stimulating hormone levels. Close attention needs to be paid to the quality of life of GO patients.
使用格雷夫斯眼眶病生活质量问卷(GO-QOL)评估格雷夫斯眼眶病(GO)患者的生活质量,并探讨GO患者生活质量的影响因素。这是一项在南方医科大学第三附属医院进行的横断面研究,纳入了145例新诊断的GO患者。所有患者均回答了GO-QOL问卷,并接受了眼科和内分泌评估。主要观察指标为GO-QOL 2个分量表的得分:视觉功能和外观。根据欧洲格雷夫斯眼眶病专家组(EUGOGO)指南中的分类,将患者分为两组:轻度组和中度至重度组。然后比较两组之间的量表得分并分析影响因素。最后,评估地板效应和天花板效应。145例GO患者视觉功能和外观分量表的GO-QOL得分分别为70.91±27.83和61.29±26.37。中度至重度组的视觉功能和外观得分(分别为62.71±28.77和57.52±26.49)低于轻度组(分别为85.58±18.77和68.02±24.99)。视觉功能分量表的GO-QOL得分与年龄(=0.002)、临床活动评分(=0.011)和复视程度(=0.00,(2)=0.373)显著相关。外观的GO-QOL得分与性别(=0.05)和促甲状腺激素水平(=0.001,(2)=0.231)显著相关。GO-QOL的任何一个分量表均未观察到明显的天花板效应或地板效应。随着疾病的加重,GO患者的生活质量越来越差。GO患者生活质量的主要影响因素包括年龄、性别、复视、临床活动评分和促甲状腺激素水平。需要密切关注GO患者的生活质量。